Warning letter
Apotheca Inc [ARCHIVED]: warning letter of Jun 23, 2009
FDA warning letter 55784 · Los Angeles District Office
Key facts
| Reference number | 55784 |
|---|---|
| Company | Apotheca Inc [ARCHIVED] |
| Subject | CGMP Manufacture, Processing, Packing or Holding/Adulterated |
| Issue date | Jun 23, 2009 |
| Posted date | Jun 23, 2009 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.42(d), 211.176, 211.182, 211.42(c)(5), 211.46(d), 211.67(b), 211.188(b)(2), 211.196 |
| Inspection city | Phoenix |
| Inspection ZIP | 85006 |
| Inspection start date | Jan 28, 2009 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: